Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Apr;5(4):1097-1100.
doi: 10.3892/etm.2013.951. Epub 2013 Feb 5.

Clinical study on the application of a 2- μ m continuous wave laser in transurethral vaporesection of the prostate

Affiliations

Clinical study on the application of a 2- μ m continuous wave laser in transurethral vaporesection of the prostate

Yong Xu et al. Exp Ther Med. 2013 Apr.

Abstract

The present study aimed to evaluate the method and clinical effects of transurethral dividing vaporesection of the prostate in the management of benign prostatic hyperplasia (BPH) using the RevoIix 70 W 2-μm continuous wave (cw) laser. A total of 155 BPH patients were treated transurethrally under epidural or sacral anesthesia using the dividing vaporesection technique. Of these, 80 had a prostate volume of ≤80 ml and 75 had a prostate volume of >80 ml. Pre- and post-operative data were evaluated for prostate-specific antigens (PSAs), post-void residual volume (PVR), maximum urinary flow rate (Qmax), International Prostate Symptom Score (IPSS) and quality of life (QoL). Statistical analyses were performed using the SPSS 16.0 software. Treatment effectiveness evaluations were also conducted. In the ≤80 ml prostate volume group, the mean PSA level decreased from 3.8±0.9 to 2.6±1.3 ng/ml. The PVR, mean Qmax, IPSS and QoL score improved significantly (P<0.05) in each group but no statistically significant difference was identified between the two groups. With a shorter surgery duration, safe use and high cutting efficiency and rapid vaporization ability, the 2-μm laser vaporesection technique shows superiority compared to standard techniques in the treatment of BPH.

Keywords: 2-μm continuous wave laser; benign prostatic hyperplasia; transurethral resection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Surgical process of vaporization resection: left, operation video image; right, corresponding animation diagram. (A) Initial incision at 5 o’clock; (B) the left tip blunt dissection process; (C) resecting and segmenting left lobe.
Figure 2
Figure 2
Statistical analysis result of patients with prostate volume over 80 ml. (A) comparison of maximum urinary flow rate before operation and 12-month follow-up. (B) comparison of IPSS and Qol (quality of life) index before operation and 12-month follow-up. *P<0.05 compared with value before operation.

Similar articles

Cited by

References

    1. Wu SL, Li NC, Xiao YX, et al. Natural history of benign prostate hyperplasia. Chin Med J (Engl) 2006;119:2085–2089. - PubMed
    1. Roehrborn CG, Issa MM, Bruskewitz RC, et al. Transurethral needle ablation for benign prostatic hyperplasia: 12-month results of a prospective, multicenter U.S. study. Urology. 1998;51:415–421. - PubMed
    1. de la Rosette JJ, de Wildt MJ, Alivizatos G, Froeling FM, Debruyne FM. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: placebo versus TUMT. Urology. 1994;44:58–63. - PubMed
    1. Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines) Eur Urol. 2004;46:547–554. - PubMed
    1. Gupta N, Sivaramakrishna, Kumar R, Dogra PN, Seth A. Comparison of standard transurethral resection, transurethral vapour resection and holmium laser enucleation of the prostate for managing benign prostatic hyperplasia of >40 g. BJU Int. 2006;97:85–89. - PubMed

LinkOut - more resources